62 related articles for article (PubMed ID: 25687113)
1. Effect of previous history of cancer on survival of patients with a second cancer of the head and neck.
Jégu J; Belot A; Borel C; Daubisse-Marliac L; Trétarre B; Ganry O; Guizard AV; Bara S; Troussard X; Bouvier V; Woronoff AS; Colonna M; Velten M
Oral Oncol; 2015 May; 51(5):457-63. PubMed ID: 25687113
[TBL] [Abstract][Full Text] [Related]
2. Second primary lung cancers following a diagnosis of primary head and neck cancer.
Griffioen GH; Louie AV; de Bree R; Smit EF; Paul MA; Slotman BJ; Leemans CR; Senan S
Lung Cancer; 2015 Apr; 88(1):94-9. PubMed ID: 25662386
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic position and stage at diagnosis of head and neck cancer - a nationwide study from DAHANCA.
Olsen MH; Bøje CR; Kjær TK; Steding-Jessen M; Johansen C; Overgaard J; Dalton SO
Acta Oncol; 2015 May; 54(5):759-66. PubMed ID: 25734503
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of seropositive HIV patients with head and neck squamous cell carcinoma treated with radiation therapy and chemotherapy.
Mourad WF; Hu KS; Shasha D; Concert C; Ishihara D; Lin W; Gamez ME; Lukens JN; Shourbaji RA; Ryniak M; Li Z; Culliney BE; Khorsandi AS; Tran T; Jacobson A; Manolidis S; Schantz S; Urken M; Persky MS; Harrison LB
Anticancer Res; 2013 Dec; 33(12):5511-6. PubMed ID: 24324090
[TBL] [Abstract][Full Text] [Related]
7. Survival after surgical resection of pulmonary metastases and second primary squamous cell lung carcinomas in head and neck cancer.
Geurts TW; Balm AJ; van Velthuysen ML; van Tinteren H; Burgers JA; van Zandwijk N; Klomp HM
Head Neck; 2009 Feb; 31(2):220-6. PubMed ID: 18972427
[TBL] [Abstract][Full Text] [Related]
8. Effect of routine esophageal screening in patients with head and neck cancer.
Su YY; Chen WC; Chuang HC; Guo CS; Lin YT; Luo SD; Fang FM; Chien CY
JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):350-4. PubMed ID: 23519755
[TBL] [Abstract][Full Text] [Related]
9. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases.
Rennemo E; Zätterström U; Boysen M
Laryngoscope; 2008 Aug; 118(8):1350-6. PubMed ID: 18496157
[TBL] [Abstract][Full Text] [Related]
10. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis.
Chow TL; Lee DT; Choi CY; Chan TT; Lam SH
Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):882-5. PubMed ID: 19770420
[TBL] [Abstract][Full Text] [Related]
11. Second primary lung malignancy in head and neck cancer patients.
Dequanter D; Shahla M; Lardinois I; Gilbert O; Hanquet O; Tragas G; Van Meerhæghe A; Lothaire P
Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Jan; 128(1):11-3. PubMed ID: 20850406
[TBL] [Abstract][Full Text] [Related]
12. Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor.
Bongers V; Snow GB; de Vries N; Cattan AR; Hall AG; van der Waal I; Braakhuis BJ
Lab Invest; 1995 Oct; 73(4):503-10. PubMed ID: 7474922
[TBL] [Abstract][Full Text] [Related]
13. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.
Jégu J; Binder-Foucard F; Borel C; Velten M
Oral Oncol; 2013 Jan; 49(1):9-14. PubMed ID: 22840787
[TBL] [Abstract][Full Text] [Related]
14. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma.
Kokko LL; Hurme S; Maula SM; Alanen K; Grénman R; Kinnunen I; Ventelä S
Oral Oncol; 2011 Jun; 47(6):510-6. PubMed ID: 21514878
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer.
Imai R; Takenaka Y; Yasui T; Nakahara S; Yamamoto Y; Hanamoto A; Takemoto N; Fukusumi T; Cho H; Yamamoto M; Inohara H
Acta Otolaryngol; 2015 Mar; 135(3):295-301. PubMed ID: 25622661
[TBL] [Abstract][Full Text] [Related]
16. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
[TBL] [Abstract][Full Text] [Related]
17. Thyroid carcinoma associated with squamous cell carcinoma of the head and neck: which policy?
Guzzo M; Quattrone P; Seregni E; Bianchi R; Mattavelli F
Head Neck; 2007 Jan; 29(1):33-7. PubMed ID: 16983696
[TBL] [Abstract][Full Text] [Related]
18. Why are head and neck squamous cell carcinoma diagnosed so late? Influence of health care disparities and socio-economic factors.
Adrien J; Bertolus C; Gambotti L; Mallet A; Baujat B
Oral Oncol; 2014 Feb; 50(2):90-7. PubMed ID: 24268629
[TBL] [Abstract][Full Text] [Related]
19. Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients.
Datema FR; Ferrier MB; van der Schroeff MP; Baatenburg de Jong RJ
Head Neck; 2010 Jun; 32(6):728-36. PubMed ID: 19827120
[TBL] [Abstract][Full Text] [Related]
20. Survival outcomes for second primary head and neck cancer: a matched analysis.
Bhattacharyya N; Nayak VK
Otolaryngol Head Neck Surg; 2005 Jan; 132(1):63-8. PubMed ID: 15632911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
